Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vicarious Surgical to Report Second Quarter 2023 Financial Results on July 27, 2023 By: Vicarious Surgical Inc. via Business Wire July 13, 2023 at 16:15 PM EDT Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the second quarter ended June 30, 2023, after the market closes on Thursday, July 27, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 (404) 975 4839 for domestic callers or clicking this link for international callers, and using access code: 114480. A live and archived webcast of the event will be available at https://investor.vicarioussurgical.com. About Vicarious Surgical Founded in 2014, Vicarious Surgical is a next generation surgical robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230713024824/en/Contacts Investor Contact Kaitlyn Brosco Vicarious Surgical Kbrosco@vicarioussurgical.com Marissa Bych Gilmartin Group Marissa@gilmartinir.com Media Inquiries Abby Mayo for Matter Health media@vicarioussurgical.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Vicarious Surgical to Report Second Quarter 2023 Financial Results on July 27, 2023 By: Vicarious Surgical Inc. via Business Wire July 13, 2023 at 16:15 PM EDT Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the second quarter ended June 30, 2023, after the market closes on Thursday, July 27, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 (404) 975 4839 for domestic callers or clicking this link for international callers, and using access code: 114480. A live and archived webcast of the event will be available at https://investor.vicarioussurgical.com. About Vicarious Surgical Founded in 2014, Vicarious Surgical is a next generation surgical robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230713024824/en/Contacts Investor Contact Kaitlyn Brosco Vicarious Surgical Kbrosco@vicarioussurgical.com Marissa Bych Gilmartin Group Marissa@gilmartinir.com Media Inquiries Abby Mayo for Matter Health media@vicarioussurgical.com
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the second quarter ended June 30, 2023, after the market closes on Thursday, July 27, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 (404) 975 4839 for domestic callers or clicking this link for international callers, and using access code: 114480. A live and archived webcast of the event will be available at https://investor.vicarioussurgical.com. About Vicarious Surgical Founded in 2014, Vicarious Surgical is a next generation surgical robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230713024824/en/
Investor Contact Kaitlyn Brosco Vicarious Surgical Kbrosco@vicarioussurgical.com Marissa Bych Gilmartin Group Marissa@gilmartinir.com Media Inquiries Abby Mayo for Matter Health media@vicarioussurgical.com